FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI
FDA grants priority review to NDA for TAR-200 in BCG-unresponsive NMIBC
BCAN launches $1 million grant for bladder cancer research impacted by federal funding cuts
Meeting with FDA paves way for phase 3 trial of Alpha1H in NMIBC